摘要:
The invention relates to a process for making a microcrystalline dimethyl fumarate comprising a step of providing a solution of dimethyl fumarate in methanol and combining the solution with water under precipitation of microcrystalline dimethyl fumarate.
摘要:
Provided herein are tartaric acid analogs represented by the following structural formula: or a pharmaceutically acceptable salt thereof, wherein values for the variables (e.g., A, R) are as described herein. Compounds of structural formula I and pharmaceutically acceptable salts thereof are believed to be useful in overcoming tumor resistance and promoting an immune response. Accordingly, also provided herein are various methods involving compounds of structural formula I, e.g., methods of treating a cancer in a subject in need thereof.
摘要:
The present invention provides novel pharmaceutical gallium compositions, as well as methods for their preparation and methods for treating conditions and diseases such as cancer, hypercalcemia, osteoporosis, osteopenia, Paget's disease, and infections.
摘要:
The invention relates to a method for carrying out a balanced reaction, comprising the following steps: a) a low-boiling educt (E2) which is gaseous in the reaction conditions is guided through a separate, liquid, higher-boiling educt (E1) in a bubble reactor and b) unreacted educt (E2) is conveyed to a membrane module together with the product to be separated (P1), which is also in gaseous form, as feed. Said membrane module is located outside of the reactor and is suitable for vapour permeation. In said membrane module, P1 is separated off as permeate whilst E2 is recovered as retentate and returned to the reactor in a circuit until the desired quantity of educt (E1) has been converted into the target product. The method is characterised in that carbonyl compounds of formula (I) R -(CO)n1-(B)m-(CO)n2-R are used as (E1), B representing an optionally hydroxy- and/or carboxy-substituted alk(en)yl radical with 1 to 12 carbon atoms which is also optionally interrupted by an ether oxygen, a phenyl radical or a carbonyl group, R and R representing hydrogen or a hydroxyl or alkyl radical with 1 to 12 carbon atoms independently of each other or forming a saturated or unsaturated aliphatic C5 or C6 ring together with at least one carbonyl group, said ring being optionally substituted with C1-C4 alkyl and/or hydroxy and the sum of n1 and n2 being either 1 or 2 and m being 0 or 1, and in that aliphatic alcohols with 2 to 8 carbon atoms are used as (E2).
摘要:
Die Erfindung betrifft ein Verfahren zur Herstellung von Oxobutanol-Estern von polymeren Carbonsäuren, insbesondere 4-Oxo-4-(C1-C5-alkoxy)-2-butanol-Estern oder 4-Oxo-4-(hydroxy-C3-C5-alkoxy)-2-butanol-Estern von polymeren Carbonsäuren, sowie die auf diese Weise erhältlichen Produkte und deren Verwendung.
摘要:
Die Erfindung betrifft ein Verfahren zur Herstellung von Carbonsäureestern von 3-Hydroxybutanoaten (d. h. also Carbonsäureestern von 4-Oxo-2-butanolen), insbesondere Carbonsäureestern von 4-Oxo-4-(C1-C5-alkoxy)-2-butanol oder von 4-Oxo-4-(hydroxy-C3-C5-alkoxy)-2-butanol, sowie die auf diese Weise erhältlichen Produkte und deren Verwendung.
摘要:
Present invention relates to a novel and improved process for the resolution of racemic pregabalin of formula (I) into (S)-(+)-pregabalin [(S)-(+)-3-aminomethyl-5-methylhexanoic acid] of formula (III) via the novel acid addition salt [(S)-(+) 3-aminomethyl-5-methylhexanoic acid, (-)-O, O'-di-p-toluoyl-L-tartaric acid salt] of formula (II). (S)-(+)-pregabalin of formula-III has analgesic, anticonvulsant and anxiolytic properties and hence is of great therapeutic significance.
摘要:
Present invention relates to a novel and improved process for the resolution of racemic pregabalin of formula (I) into (S)-(+)-pregabalin [(S)-(+)-3-aminomethyl-5-methylhexanoic acid] of formula (III) via the novel acid addition salt [(S)-(+) 3-aminomethyl-5-methylhexanoic acid, (-)-O, O'-di-p-toluoyl-L-tartaric acid salt] of formula (II). (S)-(+)-pregabalin of formula-III has analgesic, anticonvulsant and anxiolytic properties and hence is of great therapeutic significance.
摘要:
Die vorliegende Erfindung betrifft Ester von Oligohydroxycarbonsäuren, kosmetische und pharmazeutische Mittel, die diese Ester enthalten sowie die Verwendung dieser Ester als Verdickungsmittel, speziell für tensidhaltige Zusammensetzungen.
摘要:
The present invention provides novel pharmaceutical gallium compositions, as well as methods for their preparation and methods for treating conditions and diseases such as cancer, hypercalcemia, osteoporosis, osteopenia, Paget's disease, and infections.